Fragment-based drug design and drug repositioning using multiple ligand simultaneous docking (MLSD): identifying celecoxib and template compounds as novel inhibitors of signal transducer and activator of transcription 3 (STAT3).

Source:http://linkedlifedata.com/resource/pubmed/id/21678971

J. Med. Chem. 2011 Aug 11 54 15 5592-6

Download in:

View as

General Info

PMID
21678971